Latest Breaking News On - Clinical program highlights - Page 1 : comparemela.com

enVVeno Medical Reports First Quarter 2024 Financial Results and Provides

enVVeno Medical Reports First Quarter 2024 Financial Results and Provides
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

United statesAndrew cormackRobert bermanCharing cross companyNews networkVveno medical corporation nasdaqVveno medical corporation the companyVveno medical corporationClinical programAnnual charing crossMedical corporationChief commercial officerCorporate highlightsChief commercialClinical program highlightsSurgical replacement venous valve

Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones

- On track to report interim Phase 1 data for VG-3927 in healthy volunteers in mid-2024 and Phase 2 results from IGNITE clinical trial evaluating iluzanebart in ALSP in Q3 2024 - - Extends projected.

Megan mcgrathIvana magovLeah gibsonKey clinical programEuropean commissionVigil neuroscience incInvestor relations corporate communicationsDrug administrationExchange commissionHealthcare conferenceChief executive officerClinical program highlightsInvestigational new drugCorporate highlightsVigil neuroscienceQuarterly report

Vigil Neuroscience (VIGL) Issues 2023 Update, Highlights 2024 Milestones

Vigil Neuroscience (VIGL) Issues 2023 Update, Highlights 2024 Milestones
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ivana magovEuropean commissionVigil neuroscience incDrug administrationKey clinical programVigil neuroscienceChief executive officerClinical program highlightsInvestigational new drugCorporate highlightsHealthcare conference

Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones

Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Leah gibsonMegan mcgrathIvana magovKey clinical programDrug administrationEuropean commissionInvestor relations corporate communicationsExchange commissionVigil neuroscience incHealthcare conferenceChief executive officerClinical program highlightsInvestigational new drugCorporate highlightsVigil neuroscienceQuarterly report

Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Results

15.05.2023 - Last Patient Completed Blinded Treatment in REBUILD Phase 3 Trial for INOpulse; Pivotal Top-line Data Expected in Mid-2023 WARREN, N.J., May 15, 2023 (GLOBE NEWSWIRE) - Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the .

New jerseyUnited statesBaylor biosciencesBrian ritchieBaylor biosciences incExchange commissionJersey technology business tax certificate transfer programClinical programClinical program highlightsInterstitial lung diseaseVigorous physical activityQuarter ended marchFinancial resultsPrivate securities litigation reform actAnnual reportSci advisors